Efficacy and tolerability of hyaluronic acid, tea tree oil and methyl-sulfonyl-methane in a new gel medical device for treatment of haemorrhoids in a double-blind, placebo-controlled clinical trial

Updates in Surgery

Volumn 64, Issue 3, 2012, Pages 195-201

  Joksimovic, N ^a   Spasovski, G ^a   Joksimovic, V ^a   Andreevski, V ^a   Zuccari, C ^b   Omini, C F ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b R and D Unit BSD Pharma   (Italy)

Author keywords

Clinical study; Gel medical device; Haemorrhoids; Hyaluronic acid; Methyl sulfonyl methane; Tea tree oil

Indexed keywords

ANTIINFLAMMATORY AGENT; DIMETHYL SULFONE; DIMETHYL SULFOXIDE; HYALURONIC ACID; SULFONE; TEA TREE OIL; VISCOSUPPLEMENT;

ADOLESCENT; ANAL CANAL; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMBINATION; DRUG TOLERANCE; EQUIPMENT DESIGN; FEMALE; GEL; HEMORRHOID; HUMAN; MALE; PAIN; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ANAL CANAL; ANTI-INFLAMMATORY AGENTS; DIMETHYL SULFOXIDE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; DRUG TOLERANCE; EQUIPMENT DESIGN; FEMALE; GELS; HEMORRHOIDS; HUMANS; HYALURONIC ACID; MALE; PAIN; PAIN MEASUREMENT; SULFONES; TEA TREE OIL; VISCOSUPPLEMENTS;

EID: 84871869987     PISSN: 2038131X     EISSN: 20383312     Source Type: Journal    
DOI: 10.1007/s13304-012-0153-4     Document Type: Article

References (18)

1. Acheson AG, Scholenfield JH (2008) Management of haemorrhoids. BMJ 336:380-383 (Pubitemid 351300374)
2. Nisar PJ, Scholenfield JH (2003) Managing haemorrhoids. BMJ 327:847-851 (Pubitemid 37271699)
3. Hancock BD (1992) Haemorrhoids. BMJ 304:1042-1044
4. Willis S et al (2010) Haemorrhoids a collagen disease? Colorectal Dis 12:1249-1253
5. Lupo MP (2006) Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg 25:122-126 (Pubitemid 44572815)
6. Laurent TC, Fraser JRE (1992) Hyaluronan. FASEB J 6:2397-2404
7. Volpi N et al (2009) Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem 16:1718-1745
8. Kim YO et al (2009) The anti-inflammatory effects of methylsulfonylmethane on lipopolysaccharide-induced inflammation responses in murine macrophages. Biol Pharm Bull 32(4):651-656
9. Carson CF et al (2006) Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 19((1):50-62 (Pubitemid 43158450)
10. Papadopoulos CJ et al (2006) Susceptibility of pseudomonas to Melaleuca Alternifolia (tea tree) oil and components. J Antimicrob Chemother 58:449-451 (Pubitemid 44294964)
11. Burdick JA, Prestwich GD (2011) Hyaluronic acid hydrogels for biomedical applications. Adv Mater 23(12):H41-H56
12. Dechert TA et al (2006) Hyaluronan in human acute and chronic dermal wounds. Wound Rep Reg. 14:252-258 (Pubitemid 43979254)
13. Parcell S (2002) Sulphur in human nutrition and applications in medicine. Altern Med Rev. 7(1):22-44 (Pubitemid 34203978)
14. Fernandez Garcia MI et al (2009) Efficacy and safety of topical diltiazem 2% in anal fissure. Farm Hosp 33(2):80-88
15. Perrotti P et al (1999) Topical nifedipine for conservative treatment of acute haemorrhoidal thrombosis. Colorectal Dis 2:18-21
16. Gioiella G et al (2004) Clinical study on the pharmacological treatment of haemorrhoids with 0.25% oxethacaine chlorhydate. Clin Ter 155(10):443-445 (Pubitemid 44905198)
17. Tjandra JJ et al (2007) Rectogesic (glyceryl trinitrate 0.2%) ointment relieves symptoms of haemorrhoids associated with high resting anal canal pressures. Colorectal Dis 9(5):457-463 (Pubitemid 46773636)
18. Perrotti P et al (2010) Topical nifedipine with lidocaine ointment versus active control for pain after hemorrhoidectomy: results of a multicentre, prospective, randomized, double-blind study. Can J Surg 53(1):17-23